Molecular Diagnostics Market by Application (Infectious Disease (HIV, HBV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Hybridization, DNA Sequencing), End User (Hospitals, Laboratory), Product & Service (Reagent, Software) - Forecast to 2021

分子診断の世界市場予測(~2021年)

◆タイトル:Molecular Diagnostics Market by Application (Infectious Disease (HIV, HBV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Hybridization, DNA Sequencing), End User (Hospitals, Laboratory), Product & Service (Reagent, Software) - Forecast to 2021
◆商品コード:MAM-MD-2521
◆調査・発行会社:MarketsandMarkets
◆発行日:2017年2月2日
◆ページ数:243
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、分子診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、用途別分析、技術別分析、需要先別分析、製品・サービス別分析、分子診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global molecular diagnostics market is projected to reach USD 10.12 billion by 2021 from USD 6.54 billion in 2016, at a CAGR of 9.1% from 2016 to 2021. High prevalence of infectious diseases and various types of cancer, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market and advancements in molecular techniques; and reforms in the reimbursement system in the U.S. are the major factors driving the growth of the molecular diagnostics market. Advances in genomics and proteomics, increasing adoption of point-of-care testing, developing markets in Asia-Pacific such as China, India, Brazil, Mexico, and South Africa offer lucrative opportunities for players in the molecular diagnostics market.
The molecular diagnostics market is broadly segmented on the basis of technology, applications, products & services, and end user, and region. The major technologies studied in the report include PCR, INAAT, microarrays, hybridization, DNA sequencing, and Next- generation sequencing (NGS), and other technologies (electrophoresis, flow cytometry, and mass spectrometry). Among these technologies, PCR is expected to command the largest share and microarray segment is expected to be the highest growth segment.

On the basis of products and & services, the molecular diagnostics market is segmented into instruments, reagents & kits, and services & software. The reagents and & kits market is expected to account for the largest share and highest CAGR of the molecular diagnostics market in 2016.

The molecular diagnostics market, by application, is classified into six segments, namely, infectious diseases, oncology, genetics, blood screening, microbiology, and other applications (cardiovascular diseases, neurological diseases, DNA fingerprinting, tissue typing, and food pathogen detection testing). The infectious diseases segment will account for the largest share of the global molecular diagnostics market in 2016, followed by the blood screening and oncology segments.

Based on end users, the market is subsegmented into hospital & academic laboratories, reference laboratories, and other end users (blood banks, local public health laboratories, home health agencies, nursing homes, point- of- care settings, and self-testing). As most diagnostic tests are carried outperformed in-house, the hospital & academic laboratories segment is expected to dominate the market. On the other hand, newly launched, complex, and highly specialized tests are mostly offered only at a few large reference laboratories. Hence, the segment will grow at a the fastest pace during the forecast period.

On the basis of region, North America is expected to account for the largest share of the global molecular diagnostics market in 2016, followed by Europe. The growth of the North American molecular diagnostics market is majorly driven by the factors such as the availability of government funds, growing applications of MDx in genetic disorders and cancer screening, and ease of use of self-monitoring techniques.

New and iInnovative product launches was the dominant strategy adopted by key industry participants to increase their market share and cater to unmet needs.

Research Coverage:
From an insight perspective, tThis research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the molecular diagnostics market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The abovementioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to buy this report:
From an insight perspective, thThis research report focuses on various levels of analysis—industry analysis (industry trends) and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the molecular diagnostics market; high-growth regions; and market drivers, restraints, and opportunities.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on products offered by the top players in the molecular diagnostics market
• Product Development/Innovation: Detailed insights on the upcoming technologies, research & developmentR&D activities, and new product launches in the molecular diagnostics market
• Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for molecular diagnostics products across various regions
• Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the molecular diagnostics market
• Competitive Assessment: In-depth assessment of market ranking, strategies, products, and manufacturing capabilities of the leading players in the molecular diagnostics market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 19
1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKET DEFINITION 19
1.3 MARKET SCOPE 20
1.3.1 MARKETS COVERED 20
1.3.2 MOLECULAR DIAGNOSTICS MARKET, BY REGION 21
1.3.3 YEARS CONSIDERED FOR THE STUDY 21
1.4 CURRENCY 21
1.5 STAKEHOLDERS 22

2 RESEARCH METHODOLOGY 23
2.1 MARKET SIZE ESTIMATION 24
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 26
2.2.1 KEY DATA FROM SECONDARY SOURCES 28
2.2.2 KEY DATA FROM PRIMARY SOURCES 29
2.2.2.1 Key industry insights 30
2.2.3 ASSUMPTIONS 30

3 EXECUTIVE SUMMARY 31
3.1 INTRODUCTION 31
3.2 CONCLUSION 35

4 PREMIUM INSIGHTS 36
4.1 MOLECULAR DIAGNOSTICS: MARKET OVERVIEW 36
4.2 MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE OF INFECTIOUS DISEASE, 2016 VS. 2021 36
4.3 MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY AND APPLICATION 37
4.4 MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2016 VS. 2021 38
4.5 MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2016 VS. 2021 38
4.6 GEOGRAPHIC GROWTH OPPORTUNITIES: MOLECULAR DIAGNOSTICS MARKET 39

5 MARKET OVERVIEW 40
5.1 INTRODUCTION 41
5.2 MARKET DYNAMICS 41
5.2.1 DRIVERS 42
5.2.1.1 High prevalence of infectious diseases and various types of cancer 42
5.2.1.2 Increasing awareness and acceptance of personalized medicine and companion diagnostics 43

5.2.1.3 Growth in the biomarker identification market and advancements in molecular techniques 43
5.2.1.4 Reforms in the reimbursement system in the U.S. 43
5.2.2 RESTRAINTS 44
5.2.2.1 Complex regulatory frameworks to delay approvals of new molecular diagnostic tests 44
5.2.3 OPPORTUNITIES 44
5.2.3.1 Advances in genomics and proteomics 44
5.2.3.2 Increasing adoption of point-of-care testing 45
5.2.3.3 Significant growth prospects in developing countries 45
5.2.4 CHALLENGE 46
5.2.4.1 Dearth of trained professionals limiting the appropriate use of new molecular diagnostic technologies 46

6 MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 47
6.1 INTRODUCTION 48
6.2 INFECTIOUS DISEASES 49
6.2.1 CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) 52
6.2.2 HEPATITIS B 53
6.2.3 HUMAN PAPILLOMAVIRUS (HPV) 54
6.2.4 HUMAN IMMUNODEFICIENCY VIRUS (HIV) 55
6.2.5 TUBERCULOSIS (TB) 56
6.2.6 HEPATITIS C 57
6.2.7 METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) 58
6.2.8 OTHER INFECTIOUS DISEASES 59
6.3 ONCOLOGY 60
6.3.1 BREAST CANCER 63
6.3.2 COLORECTAL CANCER 64
6.3.3 PROSTATE CANCER 64
6.3.4 OTHER CANCERS 65
6.4 BLOOD SCREENING 65
6.5 GENETIC TESTS 68
6.6 MICROBIOLOGY 70
6.7 OTHER APPLICATIONS 74

7 MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 77
7.1 INTRODUCTION 78
7.2 POLYMERASE CHAIN REACTION (PCR) 79
7.3 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT) 81
7.4 HYBRIDIZATION (IN-SITU HYBRIDIZATION & FISH) 84
7.5 DNA SEQUENCING AND NEXT-GENERATION SEQUENCING 87
7.6 MICROARRAY 90
7.7 OTHER TECHNOLOGIES 94

8 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 97
8.1 INTRODUCTION 98
8.2 REAGENTS & KITS 99
8.3 INSTRUMENTS 101
8.4 SOFTWARE & SERVICES 104

9 MOLECULAR DIAGNOSTICS MARKET, BY END USER 107
9.1 INTRODUCTION 108
9.2 HOSPITAL AND ACADEMIC LABORATORIES 109
9.3 REFERENCE LABORATORIES 111
9.4 OTHER END USERS 114

10 MOLECULAR DIAGNOSTICS MARKET, BY REGION 118
10.1 INTRODUCTION 119
10.2 NORTH AMERICA 120
10.2.1 U.S. 124
10.2.2 CANADA 126
10.3 EUROPE 129
10.3.1 GERMANY 133
10.3.2 FRANCE 135
10.3.3 ITALY 137
10.3.4 SPAIN 139
10.3.5 U.K. 141
10.3.6 REST OF EUROPE (ROE) 143
10.4 ASIA-PACIFIC 145
10.4.1 JAPAN 150
10.4.2 CHINA 152
10.4.3 AUSTRALIA 154
10.4.4 INDIA 156
10.4.5 REST OF ASIA-PACIFIC (ROAPAC) 158
10.5 REST OF THE WORLD (ROW) 161
10.5.1 LATIN AMERICA 163
10.5.1.1 Brazil 166
10.5.1.2 Mexico 168
10.5.1.3 Rest of Latin America (RoLA) 170
10.5.2 MIDDLE EAST & AFRICA 172

11 COMPETITIVE LANDSCAPE 175
11.1 OVERVIEW 175
11.2 MARKET SHARE ANALYSIS 176
11.3 MOLECULAR DIAGNOSTICS MARKET COMPETITOR SHARE ANALYSIS, BY APPLICATION 177
11.3.1 MARKET SHARE ANALYSIS FOR BLOOD SCREENING APPLICATIONS 177
11.3.2 RANKING FOR MICROBIOLOGY APPLICATIONS 178
11.4 MOLECULAR DIAGNOSTICS MARKET SHARE ANALYSIS, BY TECHNOLOGY 179
11.4.1 POLYMERASE CHAIN REACTION (PCR) 179
11.4.2 DNA SEQUENCING AND NGS 180
11.4.3 MICROARRAY 182
11.4.4 HYBRIDIZATION (IN SITU AND FLUORESCENCE) 183
11.4.5 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT) 183
11.5 NEW PRODUCT LAUNCHES AND APPROVALS 185
11.6 AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, JOINT VENTURES, AND CONTRACTS 186
11.7 ACQUISITIONS 187
11.8 OTHER STRATEGIES 188

12 COMPANY PROFILES 189
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 INTRODUCTION 189
12.2 ABBOTT LABORATORIES 190
12.3 QIAGEN N.V. 194
12.4 ROCHE DIAGNOSTICS 199
12.5 HOLOGIC, INC. 205
12.6 GRIFOLS 209
12.7 SIEMENS HEALTHCARE 212
12.8 BECTON, DICKINSON AND COMPANY 214
12.9 BECKMAN COULTER INC. (A WHOLLY OWNED SUBSIDIARY OF DANAHER CORPORATION) 218
12.10 BIOMÉRIEUX SA 222
12.11 CEPHEID INC. 225
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

13 APPENDIX 228
13.1 INSIGHTS OF INDUSTRY EXPERTS 228
13.2 DISCUSSION GUIDE 229
13.3 OTHER DEVELOPMENTS 231
13.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 235
13.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 237
13.6 AVAILABLE CUSTOMIZATIONS 239
13.7 RELATED REPORTS 240
13.8 AUTHOR DETAILS 241

LIST OF TABLES

TABLE 1 MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 48
TABLE 2 INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 49
TABLE 3 NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 50
TABLE 4 EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 50
TABLE 5 ASIA-PACIFIC: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 51
TABLE 6 ROW: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 51
TABLE 7 LATIN AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 51
TABLE 8 INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC AREA,
2014–2021 (USD MILLION) 52
TABLE 9 CT/NG DIAGNOSTICS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 52
TABLE 10 CT/NG DIAGNOSTICS MARKET SIZE, BY REGION, 2014–2021 (MILLION ASSAYS) 53
TABLE 11 HEPATITIS B DIAGNOSTICS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 53
TABLE 12 HEPATITIS B DIAGNOSTICS MARKET SIZE, BY REGION,
2014–2021 (MILLION ASSAYS) 54
TABLE 13 HPV DIAGNOSTICS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 54
TABLE 14 HPV DIAGNOSTICS MARKET SIZE, BY REGION, 2014–2021 (MILLION ASSAYS) 55
TABLE 15 HIV DIAGNOSTICS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 55
TABLE 16 HIV DIAGNOSTICS MARKET SIZE, BY REGION, 2014–2021 (MILLION ASSAYS) 56
TABLE 17 TB DIAGNOSTICS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 56
TABLE 18 TB DIAGNOSTICS MARKET SIZE, BY REGION, 2014–2021 (MILLION ASSAYS) 57
TABLE 19 HEPATITIS C MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 57
TABLE 20 HEPATITIS C MARKET SIZE, BY REGION, 2014–2021 (MILLION ASSAYS) 58
TABLE 21 MRSA DIAGNOSTICS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 58
TABLE 22 MRSA DIAGNOSTICS MARKET SIZE, BY REGION, 2014–2021 (MILLION ASSAYS) 59
TABLE 23 OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 59
TABLE 24 ONCOLOGY DIAGNOSTICS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 60
TABLE 25 NORTH AMERICA: ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 61
TABLE 26 EUROPE: ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 61
TABLE 27 ASIA-PACIFIC: ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 62
TABLE 28 ROW: ONCOLOGY DIAGNOSTICS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 62
TABLE 29 LATIN AMERICA: ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 62
TABLE 30 ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 63
TABLE 31 BREAST CANCER DIAGNOSTICS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 63
TABLE 32 COLORECTAL CANCER DIAGNOSTICS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 64
TABLE 33 PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 64
TABLE 34 OTHER CANCER DIAGNOSTICS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 65
TABLE 35 BLOOD SCREENING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 65
TABLE 36 NORTH AMERICA: BLOOD SCREENING MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 66
TABLE 37 EUROPE: BLOOD SCREENING MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 66
TABLE 38 ASIA-PACIFIC: BLOOD SCREENING MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 67
TABLE 39 ROW: BLOOD SCREENING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 67
TABLE 40 LATIN AMERICA: BLOOD SCREENING MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 67
TABLE 41 GENETIC TESTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 68
TABLE 42 NORTH AMERICA: GENETIC TESTS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 68
TABLE 43 EUROPE: GENETIC TESTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 69
TABLE 44 ASIA-PACIFIC: GENETIC TESTS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 69
TABLE 45 ROW: GENETIC TESTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 69
TABLE 46 LATIN AMERICA: GENETIC TESTS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 70
TABLE 47 MICROBIOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 71
TABLE 48 NORTH AMERICA: MICROBIOLOGY MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 71
TABLE 49 EUROPE: MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 72
TABLE 50 ASIA-PACIFIC: MICROBIOLOGY MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 72
TABLE 51 ROW: MICROBIOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 73
TABLE 52 LATIN AMERICA: MICROBIOLOGY MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 73
TABLE 53 OTHER MOLECULAR DIAGNOSTIC APPLICATIONS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 74
TABLE 54 NORTH AMERICA: OTHER MOLECULAR DIAGNOSTIC APPLICATIONS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 74
TABLE 55 EUROPE: OTHER MOLECULAR DIAGNOSTIC APPLICATIONS MARKET SIZE,
BY COUNTRY, 2014–2021 (USD MILLION) 75
TABLE 56 ASIA-PACIFIC: OTHER MOLECULAR DIAGNOSTIC APPLICATIONS MARKET SIZE,
BY COUNTRY, 2014–2021 (USD MILLION) 75
TABLE 57 ROW: OTHER MOLECULAR DIAGNOSTIC APPLICATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 76
TABLE 58 LATIN AMERICA: OTHER MOLECULAR DIAGNOSTIC APPLICATIONS MARKET SIZE,
BY COUNTRY, 2014–2021 (USD MILLION) 76
TABLE 59 MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 78
TABLE 60 MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR, BY REGION,
2014–2021 (USD MILLION) 79
TABLE 61 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR,
BY COUNTRY, 2014–2021 (USD MILLION) 79
TABLE 62 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR, BY COUNTRY,
2014–2021 (USD MILLION) 80
TABLE 63 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR, BY COUNTRY, 2014–2021 (USD MILLION) 80
TABLE 64 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR, BY REGION,
2014–2021 (USD MILLION) 81
TABLE 65 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR, BY COUNTRY, 2014–2021 (USD MILLION) 81
TABLE 66 MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT, BY REGION,
2014–2021 (USD MILLION) 82
TABLE 67 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT,
BY COUNTRY, 2014–2021 (USD MILLION) 82
TABLE 68 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT, BY COUNTRY, 2014–2021 (USD MILLION) 83
TABLE 69 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT, BY COUNTRY, 2014–2021 (USD MILLION) 83
TABLE 70 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT, BY REGION,
2014–2021 (USD MILLION) 84
TABLE 71 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT,
BY COUNTRY, 2014–2021 (USD MILLION) 84
TABLE 72 MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION, BY REGION,
2014–2021 (USD MILLION) 85
TABLE 73 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION, BY COUNTRY, 2014–2021 (USD MILLION) 85
TABLE 74 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION,
BY COUNTRY, 2014–2021 (USD MILLION) 86
TABLE 75 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION,
BY COUNTRY, 2014–2021 (USD MILLION) 86
TABLE 76 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION, BY REGION, 2014–2021 (USD MILLION) 87
TABLE 77 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION,
BY COUNTRY, 2014–2021 (USD MILLION) 87
TABLE 78 MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS,
BY REGION, 2014–2021 (USD MILLION) 88
TABLE 79 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS, BY COUNTRY, 2014–2021 (USD MILLION) 88
TABLE 80 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS, BY COUNTRY, 2014–2021 (USD MILLION) 89
TABLE 81 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS, BY COUNTRY, 2014–2021 (USD MILLION) 89
TABLE 82 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS, BY REGION, 2014–2021 (USD MILLION) 90
TABLE 83 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS, BY COUNTRY, 2014–2021 (USD MILLION) 90
TABLE 84 MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS, BY REGION,
2014–2021 (USD MILLION) 91
TABLE 85 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS, BY COUNTRY, 2014–2021 (USD MILLION) 91
TABLE 86 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS,
BY COUNTRY, 2014–2021 (USD MILLION) 92
TABLE 87 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS,
BY COUNTRY, 2014–2021 (USD MILLION) 92
TABLE 88 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS, BY REGION, 2014–2021 (USD MILLION) 93
TABLE 89 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS,
BY COUNTRY, 2014–2021 (USD MILLION) 93
TABLE 90 MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY REGION, 2014–2021 (USD MILLION) 94
TABLE 91 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY COUNTRY, 2014–2021 (USD MILLION) 94
TABLE 92 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY COUNTRY, 2014–2021 (USD MILLION) 95
TABLE 93 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY COUNTRY, 2014–2021 (USD MILLION) 95
TABLE 94 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES,
BY REGION, 2014–2021 (USD MILLION) 96
TABLE 95 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY COUNTRY, 2014–2021 (USD MILLION) 96
TABLE 96 MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCTS & SERVICES,
2014–2021 (USD MILLION) 98
TABLE 97 MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 99
TABLE 98 NORTH AMERICA: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET SIZE,
BY COUNTRY, 2014–2021 (USD MILLION) 99
TABLE 99 EUROPE: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 100
TABLE 100 ASIA-PACIFIC: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET SIZE,
BY COUNTRY, 2014–2021 (USD MILLION) 100
TABLE 101 ROW: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 101
TABLE 102 LATIN AMERICA: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET SIZE,
BY COUNTRY, 2014–2021 (USD MILLION) 101
TABLE 103 MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 102
TABLE 104 NORTH AMERICA: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE,
BY COUNTRY, 2014–2021 (USD MILLION) 102
TABLE 105 EUROPE: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 102
TABLE 106 ASIA-PACIFIC: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE,
BY COUNTRY, 2014–2021 (USD MILLION) 103
TABLE 107 ROW: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 103
TABLE 108 LATIN AMERICA: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE,
BY COUNTRY, 2014–2021 (USD MILLION) 103
TABLE 109 MOLECULAR DIAGNOSTIC SOFTWARE & SERVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 104
TABLE 110 NORTH AMERICA: MOLECULAR DIAGNOSTIC SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 104
TABLE 111 EUROPE: MOLECULAR DIAGNOSTIC SOFTWARE & SERVICES MARKET SIZE,
BY COUNTRY, 2014–2021 (USD MILLION) 105
TABLE 112 ASIA-PACIFIC: MOLECULAR DIAGNOSTIC SOFTWARE & SERVICES MARKET SIZE,
BY COUNTRY, 2014–2021 (USD MILLION) 105
TABLE 113 ROW: MOLECULAR DIAGNOSTIC SOFTWARE & SERVICES MARKET SIZE,
BY REGION, 2014–2021 (USD MILLION) 106
TABLE 114 LATIN AMERICA: MOLECULAR DIAGNOSTIC SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 106
TABLE 115 MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 108
TABLE 116 MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL AND ACADEMIC LABORATORIES, BY REGION, 2014–2021 (USD MILLION) 109
TABLE 117 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL AND ACADEMIC LABORATORIES, BY COUNTRY, 2014–2021 (USD MILLION) 109
TABLE 118 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL AND ACADEMIC LABORATORIES, BY COUNTRY, 2014–2021 (USD MILLION) 110
TABLE 119 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL AND ACADEMIC LABORATORIES, BY COUNTRY, 2014–2021 (USD MILLION) 110
TABLE 120 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL AND ACADEMIC LABORATORIES, BY REGION, 2014–2021 (USD MILLION) 111
TABLE 121 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL AND ACADEMIC LABORATORIES, BY COUNTRY, 2014–2021 (USD MILLION) 111
TABLE 122 MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES,
BY REGION, 2014–2021 (USD MILLION) 112
TABLE 123 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY COUNTRY, 2014–2021 (USD MILLION) 112
TABLE 124 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY COUNTRY, 2014–2021 (USD MILLION) 113
TABLE 125 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY COUNTRY, 2014–2021 (USD MILLION) 113
TABLE 126 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY REGION, 2014–2021 (USD MILLION) 114
TABLE 127 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY COUNTRY, 2014–2021 (USD MILLION) 114
TABLE 128 MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY REGION, 2014–2021 (USD MILLION) 115
TABLE 129 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2014–2021 (USD MILLION) 115
TABLE 130 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS,
BY COUNTRY, 2014–2021 (USD MILLION) 116
TABLE 131 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2014–2021 (USD MILLION) 116
TABLE 132 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS,
BY REGION, 2014–2021 (USD MILLION) 117
TABLE 133 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2014–2021 (USD MILLION) 117
TABLE 134 MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 120
TABLE 135 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 120
TABLE 136 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 121
TABLE 137 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 123
TABLE 138 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE,
BY PRODUCT AND SERVICE, 2014–2021 (USD MILLION) 123
TABLE 139 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 124
TABLE 140 U.S.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 125
TABLE 141 U.S.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 125
TABLE 142 U.S.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE,
2014–2021 (USD MILLION) 126
TABLE 143 U.S.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 126
TABLE 144 CANADA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 127
TABLE 145 CANADA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 128
TABLE 146 CANADA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014–2021 (USD MILLION) 128
TABLE 147 CANADA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 129
TABLE 148 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 130
TABLE 149 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 131
TABLE 150 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 131
TABLE 151 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014–2021 (USD MILLION) 132
TABLE 152 EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 132
TABLE 153 GERMANY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 133
TABLE 154 GERMANY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 134
TABLE 155 GERMANY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014–2021 (USD MILLION) 134
TABLE 156 GERMANY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 135
TABLE 157 FRANCE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 135
TABLE 158 FRANCE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 136
TABLE 159 FRANCE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014–2021 (USD MILLION) 136
TABLE 160 FRANCE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 137
TABLE 161 ITALY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 137
TABLE 162 ITALY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 138
TABLE 163 ITALY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014–2021 (USD MILLION) 138
TABLE 164 ITALY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 139
TABLE 165 SPAIN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 139
TABLE 166 SPAIN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 140
TABLE 167 SPAIN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014–2021 (USD MILLION) 140
TABLE 168 SPAIN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 141
TABLE 169 U.K.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 142
TABLE 170 U.K.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 142
TABLE 171 U.K.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE,
2014–2021 (USD MILLION) 143
TABLE 172 U.K.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 143
TABLE 173 ROE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 144
TABLE 174 ROE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 144
TABLE 175 ROE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014–2021 (USD MILLION) 145
TABLE 176 ROE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 145
TABLE 177 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 146
TABLE 178 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 147
TABLE 179 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 149
TABLE 180 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE,
BY PRODUCT AND SERVICE, 2014–2021 (USD MILLION) 149
TABLE 181 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 150
TABLE 182 JAPAN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 151
TABLE 183 JAPAN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 151
TABLE 184 JAPAN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014–2021 (USD MILLION) 152
TABLE 185 JAPAN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 152
TABLE 186 CHINA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 153
TABLE 187 CHINA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 153
TABLE 188 CHINA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014–2021 (USD MILLION) 154
TABLE 189 CHINA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 154
TABLE 190 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 155
TABLE 191 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 155
TABLE 192 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014–2021 (USD MILLION) 156
TABLE 193 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 156
TABLE 194 INDIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 157
TABLE 195 INDIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 157
TABLE 196 INDIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014–2021 (USD MILLION) 158
TABLE 197 INDIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 158
TABLE 198 ROAPAC: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 159
TABLE 199 ROAPAC: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 159
TABLE 200 ROAPAC: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014–2021 (USD MILLION) 160
TABLE 201 ROAPAC: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 160
TABLE 202 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 161
TABLE 203 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 162
TABLE 204 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 162
TABLE 205 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014–2021 (USD MILLION) 163
TABLE 206 ROW: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 163
TABLE 207 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 164
TABLE 208 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION) 165
TABLE 209 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 165
TABLE 210 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE,
BY PRODUCT AND SERVICE, 2014–2021 (USD MILLION) 166
TABLE 211 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 166
TABLE 212 BRAZIL: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 167
TABLE 213 BRAZIL: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 167
TABLE 214 BRAZIL: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014–2021 (USD MILLION) 168
TABLE 215 BRAZIL: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 168
TABLE 216 MEXICO: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 169
TABLE 217 MEXICO: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 169
TABLE 218 MEXICO: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014–2021 (USD MILLION) 170
TABLE 219 MEXICO: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 170
TABLE 220 ROLA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 171
TABLE 221 ROLA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 171
TABLE 222 ROLA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014–2021 (USD MILLION) 172
TABLE 223 ROLA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 172
TABLE 224 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET SIZE,
BY TECHNOLOGY, 2014–2021 (USD MILLION) 173
TABLE 225 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET SIZE,
BY APPLICATION, 2014–2021 (USD MILLION) 173
TABLE 226 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET SIZE,
BY PRODUCT AND SERVICE, 2014–2021 (USD MILLION) 174
TABLE 227 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 174
TABLE 228 NEW PRODUCT LAUNCHES AND APPROVALS, 2013–2016 185
TABLE 229 AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, JOINT VENTURES,
AND CONTRACTS, 2013–2016 186
TABLE 230 ACQUISITIONS, 2014–2016 187
TABLE 231 OTHER STRATEGIES, 2013–2016 188


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 23
FIGURE 2 MOLECULAR DIAGNOSTICS MARKET: TOP-DOWN APPROACH 25
FIGURE 3 MOLECULAR DIAGNOSTICS MARKET: BOTTOM-UP APPROACH 25
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 26
FIGURE 5 MARKET DATA TRIANGULATION METHODOLOGY 27
FIGURE 6 MOLECULAR DIAGNOSTICS MARKET SNAPSHOT (2016 VS. 2021) 31
FIGURE 7 MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT & SERVICE,
2016 VS. 2021 32
FIGURE 8 MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2016 VS. 2021 32
FIGURE 9 MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2016 VS. 2021 33
FIGURE 10 MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2016 VS. 2021 34
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE MOLECULAR DIAGNOSTICS MARKET 34
FIGURE 12 RISING PREVALENCE OF INFECTIOUS DISEASES & CANCER TO DRIVE MARKET GROWTH 36
FIGURE 13 MRSA TO BE THE FASTEST-GROWING SEGMENT DURING THE FORECAST PERIOD 36
FIGURE 14 INFECTIOUS DISEASES SEGMENT TO DOMINATE THE MOLECULAR DIAGNOSTICS MARKET IN 2016 37
FIGURE 15 HOSPITALS & ACADEMIC LABORATORIES WILL CONTINUE TO DOMINATE THE MOLECULAR DIAGNOSTICS MARKET IN 2021 38
FIGURE 16 REAGENTS & KITS TO GROW AT THE HIGHEST RATE BETWEEN 2016 & 2021 38
FIGURE 17 ASIA-PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 39
FIGURE 18 MOLECULAR DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND THREATS 41
FIGURE 19 GROWTH IN THE NUMBER OF PEOPLE LIVING WITH HIV IN 2010 AND 2015 (MILLIONS) 42
FIGURE 20 INFECTIOUS DISEASES SEGMENT TO DOMINATE THE MOLECULAR DIAGNOSTIC APPLICATIONS MARKET DURING THE FORECAST PERIOD 48
FIGURE 21 PCR TO DOMINATE THE MOLECULAR DIAGNOSTIC TECHNOLOGIES MARKET DURING THE FORECAST PERIOD 78
FIGURE 22 REAGENTS & KITS TO FORM THE LARGEST SEGMENT OF THE MOLECULAR DIAGNOSTICS MARKET IN 2016 98
FIGURE 23 HOSPITAL AND ACADEMIC LABORATORIES—THE MAJOR END USERS OF MOLECULAR DIAGNOSTICS 108
FIGURE 24 ASIA-PACIFIC WILL BE THE FASTEST-GROWING REGION IN THE MOLECULAR DIAGNOSTICS MARKET 119
FIGURE 25 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET SNAPSHOT 122
FIGURE 26 GERMANY, THE DOMINANT COUNTRY IN THE EUROPEAN MOLECULAR DIAGNOSTICS MARKET 130
FIGURE 27 JAPAN WILL CONTINUE TO LEAD THE ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET 146
FIGURE 28 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SNAPSHOT 148
FIGURE 29 LATIN AMERICA WILL CONTINUE TO LEAD THE ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET DURING THE FORECAST PERIOD 161
FIGURE 30 BRAZIL TO COMMAND THE LARGEST SHARE OF THE LATIN AMERICAN MOLECULAR DIAGNOSTICS MARKET IN 2021 164
FIGURE 31 PRODUCT LAUNCHES AND APPROVALS: KEY STRATEGIES ADOPTED IN THE LAST THREE YEARS 175
FIGURE 32 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2015 176
FIGURE 33 GLOBAL BLOOD SCREENING MARKET SHARE, BY KEY PLAYER, 2015 177
FIGURE 34 GLOBAL MICROBIOLOGY, KEY PLAYER RANKING, 2014 179
FIGURE 35 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR PCR, MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015 180
FIGURE 36 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING AND NGS, MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015 181
FIGURE 37 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR MICROARRAY,
MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015 182
FIGURE 38 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR HYBRIDIZATION,
KEY PLAYER RANKING, 2015 183
FIGURE 39 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR INAAT,
KEY PLAYER RANKING, 2015 184
FIGURE 40 BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES AND APPROVALS WAS THE KEY GROWTH STRATEGY 184
FIGURE 41 GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS 189
FIGURE 42 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2015) 190
FIGURE 43 QIAGEN N.V.: COMPANY SNAPSHOT (2015) 194
FIGURE 44 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2015) 199
FIGURE 45 HOLOGIC, INC.: COMPANY SNAPSHOT (2015) 205
FIGURE 46 GRIFOLS: COMPANY SNAPSHOT (2015) 209
FIGURE 47 SIEMENS HEALTHCARE: COMPANY SNAPSHOT (2016) 212
FIGURE 48 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2015) 214
FIGURE 49 DANAHER CORPORATION: COMPANY SNAPSHOT (2015) 218
FIGURE 50 BIOMÉRIEUX: COMPANY SNAPSHOT (2015) 222
FIGURE 51 CEPHEID INC.: COMPANY SNAPSHOT (2015) 225


【レポートのキーワード】

分子診断、分子診断用途、分子病理学、感染症検査、癌検査、医療、分子診断技術、PCR、DNAシークエンス

★調査レポート[分子診断の世界市場予測(~2021年)] ( Molecular Diagnostics Market by Application (Infectious Disease (HIV, HBV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Hybridization, DNA Sequencing), End User (Hospitals, Laboratory), Product & Service (Reagent, Software) - Forecast to 2021 / MAM-MD-2521) 販売に関する免責事項
[分子診断の世界市場予測(~2021年)] ( Molecular Diagnostics Market by Application (Infectious Disease (HIV, HBV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Hybridization, DNA Sequencing), End User (Hospitals, Laboratory), Product & Service (Reagent, Software) - Forecast to 2021 / MAM-MD-2521) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆